Par Drugs and Chemicals Limited
NSE:PAR.NS
302.6 (INR) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 346.569 | 226.056 | 228.192 | 239.991 | 258.873 | 229.347 | 238.379 | 229.327 | 248.18 | 235.065 | 212.064 | 169.155 | 195.948 | 164.834 | 153.408 | 162.719 | 141.336 | 141.336 | 133.686 | 133.686 | 145.557 | 145.557 | 107.309 | 107.309 | 124.308 | 124.308 |
Cost of Revenue
| 143.26 | 74.861 | 99.264 | 101.517 | 110.239 | 116.247 | 349.154 | 102.592 | 104.247 | 108.057 | 304.584 | 64.919 | 68.128 | 61.006 | 206.927 | 61.477 | 52.984 | 52.984 | 59.923 | 59.923 | 61.603 | 61.603 | 42.04 | 42.04 | 54.067 | 54.067 |
Gross Profit
| 203.309 | 151.195 | 128.928 | 138.474 | 148.634 | 113.1 | -110.775 | 126.735 | 143.933 | 127.008 | -92.52 | 104.236 | 127.82 | 103.828 | -53.519 | 101.242 | 88.353 | 88.353 | 73.763 | 73.763 | 83.955 | 83.955 | 65.268 | 65.268 | 70.241 | 70.241 |
Gross Profit Ratio
| 0.587 | 0.669 | 0.565 | 0.577 | 0.574 | 0.493 | -0.465 | 0.553 | 0.58 | 0.54 | -0.436 | 0.616 | 0.652 | 0.63 | -0.349 | 0.622 | 0.625 | 0.625 | 0.552 | 0.552 | 0.577 | 0.577 | 0.608 | 0.608 | 0.565 | 0.565 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 2.775 | 0 | 0 | 0 | 1.217 | 0 | 0 | 0 | 0.988 | 0 | 0 | 0 | 0.333 | 0.333 | 0 | 0 | 0.272 | 0.272 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 98.308 | 12.617 | 76.908 | 94.837 | 83.487 | 80.09 | 15.575 | 13.393 | 74.546 | 80.546 | 69.102 | 58.377 | 77.767 | 53.708 | 12.02 | 10.385 | 8.69 | 8.69 | 10.368 | 10.368 | 10.2 | 10.2 | 7.916 | 7.916 | 10.559 | 10.559 |
Other Expenses
| 0 | 117.883 | -0.48 | 2.291 | 0.491 | 0.121 | 0 | 0.377 | 0.158 | 97.419 | -125.885 | 0.518 | 0.277 | 0.374 | -0.346 | 0.311 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 98.308 | 117.883 | 76.908 | 94.837 | 83.487 | 80.09 | -151.905 | 101.853 | 94.013 | 97.419 | -125.885 | 76.381 | 95.722 | 70.594 | -88.96 | 68.434 | 56.396 | 56.396 | 52.955 | 52.955 | 71.335 | 71.335 | 56.364 | 56.364 | 54.999 | 54.999 |
Operating Income
| 105.001 | 33.312 | 52.02 | 43.637 | 65.147 | 33.01 | 45.349 | 24.882 | 50.079 | 31.123 | 36.454 | 28.373 | 32.375 | 33.607 | 36.333 | 33.119 | 31.685 | 31.685 | 20.824 | 20.824 | 12.612 | 12.612 | 9.719 | 9.719 | 15.912 | 15.912 |
Operating Income Ratio
| 0.303 | 0.147 | 0.228 | 0.182 | 0.252 | 0.144 | 0.19 | 0.109 | 0.202 | 0.132 | 0.172 | 0.168 | 0.165 | 0.204 | 0.237 | 0.204 | 0.224 | 0.224 | 0.156 | 0.156 | 0.087 | 0.087 | 0.091 | 0.091 | 0.128 | 0.128 |
Total Other Income Expenses Net
| 9.868 | 0.538 | -0.931 | 2.095 | 0.224 | -0.036 | 0.045 | 0.081 | -0.3 | -0.467 | -0.171 | -0.99 | -2.282 | -0.334 | 17.741 | -0.49 | -1.406 | -1.406 | -1.389 | -1.389 | -2.088 | -2.088 | -3.727 | -3.727 | -5.72 | -5.72 |
Income Before Tax
| 114.869 | 33.85 | 51.089 | 45.732 | 65.371 | 32.974 | 45.394 | 24.964 | 49.779 | 30.656 | 36.283 | 27.383 | 30.093 | 33.273 | 54.074 | 32.629 | 30.279 | 30.279 | 19.435 | 19.435 | 10.524 | 10.524 | 5.991 | 5.991 | 10.192 | 10.192 |
Income Before Tax Ratio
| 0.331 | 0.15 | 0.224 | 0.191 | 0.253 | 0.144 | 0.19 | 0.109 | 0.201 | 0.13 | 0.171 | 0.162 | 0.154 | 0.202 | 0.352 | 0.201 | 0.214 | 0.214 | 0.145 | 0.145 | 0.072 | 0.072 | 0.056 | 0.056 | 0.082 | 0.082 |
Income Tax Expense
| 28.91 | 8.519 | 13.895 | 11.51 | 16.453 | 8.299 | 10.924 | 6.283 | 12.528 | 7.715 | 12.041 | 6.23 | 7.89 | 8.72 | 9.902 | 11.798 | 4.725 | 4.725 | 3.553 | 3.553 | 2.581 | 2.581 | 3.903 | 3.903 | 3.354 | 3.354 |
Net Income
| 85.958 | 25.331 | 37.194 | 34.222 | 48.918 | 24.675 | 34.47 | 18.68 | 37.251 | 22.94 | 24.242 | 21.153 | 22.203 | 24.553 | 44.172 | 20.831 | 25.555 | 25.555 | 15.882 | 15.882 | 7.943 | 7.943 | 2.088 | 2.088 | 6.839 | 6.839 |
Net Income Ratio
| 0.248 | 0.112 | 0.163 | 0.143 | 0.189 | 0.108 | 0.145 | 0.081 | 0.15 | 0.098 | 0.114 | 0.125 | 0.113 | 0.149 | 0.288 | 0.128 | 0.181 | 0.181 | 0.119 | 0.119 | 0.055 | 0.055 | 0.019 | 0.019 | 0.055 | 0.055 |
EPS
| 6.99 | 2.06 | 3.02 | 2.78 | 3.98 | 2.01 | 2.8 | 1.52 | 3.03 | 1.86 | 1.97 | 1.72 | 1.8 | 2 | 3.59 | 3.39 | 2.08 | 2.08 | 1.29 | 1.29 | 0.65 | 0.65 | 0.17 | 0.17 | 1.27 | 1.27 |
EPS Diluted
| 6.99 | 2.06 | 3.02 | 2.78 | 3.98 | 2.01 | 2.8 | 1.52 | 3.03 | 1.86 | 1.97 | 1.72 | 1.8 | 2 | 3.59 | 3.39 | 2.08 | 2.08 | 1.29 | 1.29 | 0.65 | 0.65 | 0.17 | 0.17 | 1.27 | 1.27 |
EBITDA
| 123.949 | 43.086 | 60.939 | 52.29 | 73.625 | 41.321 | 51.171 | 32.685 | 59.206 | 38.424 | 45.125 | 36.12 | 40.724 | 41.652 | 43.597 | 39.328 | 39.046 | 39.046 | 21.154 | 21.154 | 26.089 | 26.089 | 18.274 | 18.274 | 22.542 | 22.542 |
EBITDA Ratio
| 0.358 | 0.191 | 0.267 | 0.218 | 0.284 | 0.18 | 0.215 | 0.143 | 0.239 | 0.163 | 0.213 | 0.214 | 0.208 | 0.253 | 0.284 | 0.242 | 0.276 | 0.276 | 0.158 | 0.158 | 0.179 | 0.179 | 0.17 | 0.17 | 0.181 | 0.181 |